Regenxbio Inc (NASDAQ:RGNX)

19.64
Delayed Data
As of May 19
 +0.07 / +0.36%
Today’s Change
18.69
Today|||52-Week Range
46.46
-39.94%
Year-to-Date
No recent news for Regenxbio Inc.

Today’s Trading

Previous close19.57
Today’s open19.41
Day’s range18.70 - 19.89
Volume18,693
Average volume (3 months)425,576
Market cap$898.9M
Data as of 4:02pm ET, 05/19/2022

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-258.29%
Earnings growth (next 5 years)+11.81%
Revenue growth (last year)+204.30%
P/E ratio8.5
Price/Sales3.05
Price/Book1.17

Competitors

 Today’s
change
Today’s
% change
MORFMorphic Holding Inc-0.62-2.70%
SAVACassava Sciences Inc+1.79+8.03%
----
IMGNImmunoGen Inc+0.02+0.57%
Data as of 5:53pm ET, 05/19/2022

Financials

Next reporting dateAugust 10, 2022
EPS forecast (this quarter)-$1.41
Annual revenue (last year)$470.3M
Annual profit (last year)$127.8M
Net profit margin27.18%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Rockville, Maryland

Forecasts